Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,882 | 85,807 | 60,949 | N/A | N/A |
| Marketable Securities | 226,012 | 16,966 | N/A | N/A | N/A |
| Receivables | 9,362 | 7,385 | 500 | N/A | N/A |
| TOTAL | $290,754 | $111,900 | $61,733 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4,321 | 4,079 | 4,260 | N/A | N/A |
| Other Non-Current Assets | 451 | 3,085 | 536 | 0 | 0 |
| TOTAL | $4,772 | $7,164 | $4,796 | $N/A | $N/A |
| Total Assets | $295,526 | $119,064 | $66,529 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,023 | 1,250 | 2,576 | 0 | 0 |
| Accrued Expenses | 9,576 | 6,922 | 2,508 | N/A | N/A |
| TOTAL | $11,599 | $8,172 | $5,084 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 866 | 912 | 811 | 0 | 0 |
| TOTAL | $866 | $912 | $811 | $N/A | $N/A |
| Total Liabilities | $12,465 | $9,084 | $5,895 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,738 | N/A | N/A | N/A | N/A |
| Common Shares | 3 | 1 | 1 | N/A | N/A |
| Retained earnings | -117,828 | -76,295 | -71,470 | N/A | N/A |
| Other shareholders' equity | -32 | 186,274 | 132,103 | 0 | 0 |
| TOTAL | $283,061 | $109,980 | $60,634 | $N/A | $N/A |
| Total Liabilities And Equity | $295,526 | $119,064 | $66,529 | $0 | $0 |